VIA Pharmaceuticals, Inc., a development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases. It is developing a pipeline of small molecule drugs that target the underlying causes of cardiovascular and metabolic diseases...
8 insider purchases on record · latest filing 2008-12-19.
Insiders have also filed 20 sale transactions at VIAP.